邢台招聘

职位描述：
任职要求:
？具有带领技术团队的经验
？非常熟练分析高通量NGS测序数据
？具有开发和应用统计学模型及工具对人类基因组改变比如点突变，融合，扩展进行分析的经验
？非常熟练应用R、Perl、Python等脚本语言
？Java或C语言经验优先考虑
？极强的统计学与数学背景
？良好的学习和逻辑分析能力
？基本的软件开发知识及经验优先考虑
？勤奋认真，团队合作
？博士以上学历，2-4年工作经验，生物信息学等相关专业

职业经验:
？有带领生物信息团队的经验
？具备肿瘤学或遗传学相关经验者优先考虑
有产品开发经验者优先考虑 举报 分享

关于燃石医学
燃石医学（纳斯达克代码：BNR）成立于2014年，公司使命为“用科学守护生命之光”，专注于为肿瘤精准医疗提供具有临床价值的二代基因测序（NGS）。公司业务及研发方向主要覆盖：1）基于NGS的肿瘤患病人群检测，6年间，燃石累计检测样本超过18.5万例，在中国市场份额领跑行业；2）基于NGS的癌症早检，目前已经进入临床验证阶段。
燃石医学于2018年7月率先获国家药品监督管理局（NMPA）颁发的中国肿瘤NGS检测试剂盒，在体外诊断领域具有里程碑式意义。实验室获得广东省临检中心颁发的 “高通量测序实验室”技术审核，以及得美国CLIA和CAP实验室质量体系资质认证。公司将继续致力于开发创新可靠的NGS检测产品，推动肿瘤精准医疗领域的发展。

About Burning Rock
Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 185,000 tissue and liquid-based tests completed cumulatively, and ii) NGS-based cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.
In July 2018, Burning Rock received the first approval for a tumor NGS kit by the National Medical Products Administration (NMPA), which is a significant milestone in the field of in vitro diagnosis in China. Burning Rock’s laboratory has obtained the technical certification of “High-throughput sequencing laboratory” issued by Guangdong Center for Clinical Laboratory, and the CLIA and CAP laboratory quality system certification. The company continues to be committed to the development of innovative and reliable NGS testing products and promoting the development of precision medicine in oncology.